<?xml version="1.0" encoding="UTF-8"?><!-- generator="WordPress/2.7.1" -->
<rss version="0.92">
<channel>
	<title>Discuss Cancer</title>
	<link>http://discuss-cancer.com</link>
	<description>Discuss Living With and Treating Cancer</description>
	<lastBuildDate>Sun, 08 Nov 2009 10:01:10 +0000</lastBuildDate>
	<docs>http://backend.userland.com/rss092</docs>
	<language>en</language>
	
	<item>
		<title>MicroRNA&#45;Mediated Metastasis Suppression</title>
		<description>Metastases are responsible for over 90% of cancer deaths. In the upcoming issue of G&D, Dr. Robert Weinberg (MIT) and colleagues lend molecular insight into how microRNAs suppress tumor metastasis.

Scott Valastyan, lead author on the study, describes it as presenting "detailed mechanistic insight regarding the process of tumor metastasis, and ...</description>
		<link>http://discuss-cancer.com/2009/11/micrornamediated-metastasis-suppression/</link>
			</item>
	<item>
		<title>A New Explanation Of &#8216;Asian Paradox&#8217;</title>
		<description>Although Helicobacter pylori (H. pylori) has been classified as a class I (or definite) carcinogen by World Health Organization (WHO), the controversy as to why only a minority of infected patients develop gastric cancer still remains. Moreover, in Asian countries such as Indonesia, Japan, China, and Thailand, where the H. ...</description>
		<link>http://discuss-cancer.com/2009/11/a-new-explanation-of-asian-paradox/</link>
			</item>
	<item>
		<title>Toward Bold New Anti&#45;cancer Medicines</title>
		<description>Bold new strategies in the battle against cancer may turn forms of the disease that presently are incurable into manageable conditions that can be controlled for long periods of time, according to an article in the current issue of Chemical & Engineering News, ACS' weekly newsmagazine. 
C&EN Senior Editor Lisa ...</description>
		<link>http://discuss-cancer.com/2009/11/toward-bold-new-anticancer-medicines/</link>
			</item>
	<item>
		<title>Celsion And Yakult Honsha Announce Treatment Of First Patient In Japan In Celsion&#8217;s Global Phase III ThermoDox(R) Trial For Primary Liver Cancer</title>
		<description>Celsion Corporation (NASDAQ: CLSN) and Yakult Honsha Co., Ltd. (Tokyo: 2267) announced today that the first patient has been enrolled and treated in Japan as part of Celsion's global Phase III ThermoDox HEAT trial for the treatment of hepatocellular carcinoma (HCC), the most common form of primary liver cancer. 
Yakult ...</description>
		<link>http://discuss-cancer.com/2009/11/celsion-and-yakult-honsha-announce-treatment-of-first-patient-in-japan-in-celsions-global-phase-iii-thermodoxr-trial-for-primary-liver-cancer/</link>
			</item>
	<item>
		<title>$6.5 Million Gift To UCSF From Irwin And Joan Jacobs For Head And Neck Cancer Research</title>
		<description>Philanthropists Irwin and Joan Jacobs of La Jolla, CA are giving a $6.5 million gift to UCSF for head and neck cancer research. It is believed to be the largest private, U.S. gift for research supporting this disease.

Irwin Jacobs is the founder, retired CEO, and current board member of telecommunications ...</description>
		<link>http://discuss-cancer.com/2009/11/65-million-gift-to-ucsf-from-irwin-and-joan-jacobs-for-head-and-neck-cancer-research/</link>
			</item>
	<item>
		<title>$4.8M Stimulus Grant Launches Feasibility Study Of Massive Endeavor To Measure All Human Proteins</title>
		<description>An expert in cancer proteomics at Fred Hutchinson Cancer Research Center has received $4.8 million in federal stimulus funding from the National Cancer Institute to co-lead a pilot study to assess the feasibility and scalability of a project that aims to measure all of the proteins in the human body.

"If ...</description>
		<link>http://discuss-cancer.com/2009/11/48m-stimulus-grant-launches-feasibility-study-of-massive-endeavor-to-measure-all-human-proteins/</link>
			</item>
	<item>
		<title>AstraZeneca Withdraws Its Marketing Authorisation Application For Zactima (vandetinib), Europe</title>
		<description>The European Medicines Agency has been formally notified by AstraZeneca of its decision to withdraw its application for a centralised marketing authorisation for the medicine Zactima (vandetinib), 100 mg film-coated tablets. 
Zactima was expected to be used in combination with chemotherapy, for the treatment of patients with locally advanced or ...</description>
		<link>http://discuss-cancer.com/2009/11/astrazeneca-withdraws-its-marketing-authorisation-application-for-zactima-vandetinib-europe/</link>
			</item>
	<item>
		<title>Th17 Cells Summon An Immune System Strike Against Cancer</title>
		<description>A specific type of T helper cell awakens the immune system to the stealthy threat of cancer and triggers an attack of killer T cells custom-made to destroy the tumors, scientists from The University of Texas M. D. Anderson Cancer Center report in the early online edition of the journal ...</description>
		<link>http://discuss-cancer.com/2009/11/th17-cells-summon-an-immune-system-strike-against-cancer/</link>
			</item>
	<item>
		<title>A Researcher At The Technical University Of Catalonia (UPC) Designs The First Ever Synthetic Gene Circuit That Works Like That Of A Natural Cell</title>
		<description>The experiment, featured on the cover of the leading weekly science journal Cell of October 30, shows that cells use chance to survive uncertainty.
"God does not play dice," said Einstein to explain that chance does not intervene in nature. However, researcher Jordi García Ojalvo, from the Campus of the UPC ...</description>
		<link>http://discuss-cancer.com/2009/11/a-researcher-at-the-technical-university-of-catalonia-upc-designs-the-first-ever-synthetic-gene-circuit-that-works-like-that-of-a-natural-cell/</link>
			</item>
	<item>
		<title>USC Awarded New $16 Million Cancer Research Center</title>
		<description>The University of Southern California has been selected to establish a $16 million cancer research center as part of a new strategy against the disease by the U.S. National Institutes of Health and its National Cancer Institute. 
The five-year award will create a National Cancer Institute Physical Science-Oncology Center based ...</description>
		<link>http://discuss-cancer.com/2009/11/usc-awarded-new-16-million-cancer-research-center/</link>
			</item>
</channel>
</rss>
